Primer caso de infección por adenovirus después de un trasplante de riñón en Ecuador
Citas
Dawood US, Nelson A, Wu D, Otto S, Russ GR. Disseminated adenovirus infection in kidney transplant recipient. Nephrology (Carlton). 2014;19(Suppl 1):10-3.
Florescu MC, Miles CD, Florescu DF. What do we know about adenovirus in renal transplantation? Nephrol Dial Transplant. 2013;28(8):2003-10.
Parasuraman R, Zhang PL, Samarapungavan D, Rocher L, Koffron A. Severe necrotizing adenovirus tubulointerstitial nephritis in a kidney transplant recipient. Case Rep Transplant. 2013;2013:969186.
Taniguchi K, Yoshihara S, Tamaki H, Fujimoto T, Ikegame K, Kaida K, et al. Incidence and treatment strategy for disseminated adenovirus disease after haploidentical stem cell transplantation. Ann Hematol. 2012;91(8):1305-12.
Florescu DF, Hoffman JA; AST Infectious Diseases Community of Practice. Adenovirus in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):206-11.
Storsley L, Gibson IW. Adenovirus interstitial nephritis and rejection in an allograft. J Am Soc Nephrol. 2011;22(8):1423-7.
Keddis M, Leung N, Herrmann S, El-Zoghby Z, Sethi S. Adenovirus-induced interstitial nephritis following umbilical cord blood transplant for chronic lymphocytic leukemia. Am J Kidney Dis. 2012;59(6):886-90.
Sujeet K, Vasudev B, Desai P, Bellizzi J, Novoa-Takara L, He C, et al. Acute kidney injury requiring dialysis secondary to adenovirus nephritis in renal transplant recipient. Transpl Infect Dis. 2011;13(2):174-7.
Ison MG, Green M; AST Infectious Diseases Community of Practice. Adenovirus in solid organ transplant recipients. Am J Transplant. 2009;9(Suppl 4):S161-5.
Painter W, Robertson A, Trost LC, Godkin S, Lampert B, Painter G. First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses. Antimicrob Agents Chemother.
;56(5):2726-34.
Florescu DF, Pergam SA, Neely MN, Qiu F, Johnston C, Way S, et al. Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients. Biol Blood Marrow Transplant. 2012;18(5):731-8.
